PE Trademark

Trademark Overview


On Thursday, November 2, 2023, a trademark application was filed for PE with the United States Patent and Trademark Office. The USPTO has given the PE trademark a serial number of 98252986. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, September 19, 2024. This trademark is owned by Precision Epigenomics, Inc.. The PE trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of cancer

Cancer screening services; Medical screening; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical analysis services for the diagnosis of cancer; Medical diagnostic testing, monitoring and reporting services; Medical testing services relating to the diagnosis and treatment of disease
pe

General Information


Serial Number98252986
Word MarkPE
Filing DateThursday, November 2, 2023
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateThursday, September 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the stylized letters "PE" where the "P" is over and to the left of the "E", where the fill of the "P" being a gradient and the fill of the "E" being a gradient, the letters combining to form a hexagonal design.
Goods and ServicesDiagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of cancer
Pseudo MarkPRECISION EPIGENOMICS
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesCancer screening services; Medical screening; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical analysis services for the diagnosis of cancer; Medical diagnostic testing, monitoring and reporting services; Medical testing services relating to the diagnosis and treatment of disease

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 2, 2023
Primary Code005
First Use Anywhere DateThursday, April 18, 2024
First Use In Commerce DateThursday, April 18, 2024

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 2, 2023
Primary Code044
First Use Anywhere DateThursday, April 18, 2024
First Use In Commerce DateThursday, April 18, 2024

Trademark Owner History


Party NamePrecision Epigenomics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTucson, AZ 85711

Trademark Events


Event DateEvent Description
Friday, November 3, 2023NEW APPLICATION ENTERED
Sunday, January 21, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 3, 2024TEAS AMENDMENT OF USE RECEIVED
Wednesday, June 12, 2024ASSIGNED TO EXAMINER
Monday, September 16, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 16, 2024NON-FINAL ACTION WRITTEN
Monday, September 16, 2024NON-FINAL ACTION E-MAILED
Thursday, September 19, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 19, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 19, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED